FuelCell Energy logo is displayed on a smartphone screen

FuelCell Energy Ignites Short-Covering Rally, Don’t Buy Into It

FuelCell Energy logo is displayed on a smartphone screen

FuelCell Energy (NASDAQ: FCEL) is up a solid 20% following its latest earnings release on dubious news and hope. The move confirms a technical reversal in the share price, but the report's detail belies the technical outlook. The downtrend will likely continue because the stock is well below its downtrend line, with losses widening. The takeaway is that FuelCell Energy's stock price is heading higher now, but the ceiling is in sight, and another selling opportunity is developing. 

The short interest is a likely culprit for the post-release sell-off. The short interest was over 22% at the last report and sufficient fuel for a short-covering rally, if not a squeeze, so it looks like we have a squeeze in play. The squeeze could last several days, but it is not a reason to buy into this energy stock now. 

FuelCell Has Better-Than-Expected Quarter

FuelCell had a better-than-expected quarter, but that is not to say it had a good quarter. Revenue of $22.2 million is nearly 700 basis points above the consensus reported by MarketBeat but still down almost 42% compared to last year. The weakness is due entirely to a near-100% decline in service revenue due to the lapping of last year’s module exchanges with Korea South Power. The generation segment revenue increased by 65% as the generation base grew, and Advanced Technologies nearly doubled on new contracts. 

The margin news is mixed. The headline is that losses narrowed, but that is not the real story. GAAP per share losses narrowed slightly and outpaced the consensus by a penny, but due to an increased share count, there was no operational excellence. The share count is up 11% on average compared to last year, which is the only reason the GAAP losses narrowed. The company’s gross loss, operating loss, and adjusted operating losses widened compared to last year, resulting in a capital drain on the balance sheet. 

The balance sheet is still capitalized, but there are some red flags. Lack of profits aside, the company’s cash and equivalents balance is declining, assets are declining, debt is up, and liabilities are growing. The net result is that shareholder equity was reduced by 6% in addition to the 11% dilution, which is a serious headwind for the stock price. The report highlights bolstering the balance sheet with share sales (which investors should expect to continue) and debt financing for newly online projects. 

Analysts Aren’t Fired Up About FuelCell Energy 

Analysts are not fired up about this stock; instead they have left it for dead. The most recent update tracked by MarketBeat.com was issued in Q3 2023 and is a Hold with a $2 price target. That target implies more than 100% upside for this Sell-rated stock but does not reflect the recent results. Because the company is slow to gain traction and losses are mounting, analysts will unlikely change their tune soon, which will provide another headwind for the market. Institutional interest is also sketchy. The institutions own about 43% of the stock but have been selling on balance this quarter, and most of the holdings are for exchange-traded funds. 

The price action in FCEL stock is attractive, but there are risks. The market shows a Head & Shoulders on the brink of confirming reversal, but it shows resistance at the critical level, and the downtrend is still intact. The critical level is near $1.00, consistent with the pattern neckline. Failing to move above this level would confirm the downtrend and keep this name in penny stock territory. A move higher would confirm a reversal, but with the 150-day moving average at $1.15, the reversal may not go far. The 150-day EMA has been strong resistance since 2021 and is unlikely to break now. 

FuelCell FCEL stock chart

Learn more about FCEL

Newest Stories

In the System Control Room Technical Operator Works at His Workstation with Multiple Displays Showing Graphics
This Cybersecurity Stock Gains Analysts' Favor for Strong Growth

As the global economy becomes more digitized by the day, business and customer data are kept in what’s now the most common term in the technology sector: The Cloud. Companies rely on cloud computing services and artificial intelligence to make the vast databases they can access work for them...

Gabriel Osorio-Mazilli | Jul 18, 2024

Mechanic in blue workwear uniform inspects the car bottom with his assistant. Automobile repairing service
Parabolic Rise of This Stock Shows No Signs of Slowing

Cintas Corporation’s (NASDAQ: CTAS) Q4 results and guidance prove its parabolic share price movement can continue. The results continue a trend that includes organic and acquisitional growth, widening margins, robust cash flow, and capital returns. The trend has the stock price up more tha...

Thomas Hughes | Jul 18, 2024

Photo of an artistic drawing of two heads showing one with gears (representing facts) and one with clouds (representing emotions) to illustrate the concepts of risk tolerance and risk appetitie.
Risk Tolerance vs. Risk Appetite: Key Differences

Risk tolerance and risk appetite may sound like different ways to describe the same thing, but they’re actually very distinct measurements. Risk tolerance ensures that you do not take on more risk than you can emotionally handle, preventing stress and impulsive decisions, while risk appetite h...

Dan Schmidt | Jul 18, 2024

close up. scientists are testing a new vaccine . photo with copy - space.
Why This Leading Health Stock is a Buy No Matter the Market Move

Abbott  Laboratories (NYSE: ABT) is a premier buy-and-hold stock because of its foresightful management, quality operation, portfolio, pipeline, cash flow, and capital return. It’s not always a good buy; all healthcare stocks have ups and downs in their cycles, but Abbott is a buy today...

Thomas Hughes | Jul 18, 2024

TickerTalk Unveils Real-Time Financial Insights and Breaking News!